This inventor holds 2 USPTO granted patents. Top assignee: Vanderbilt University. Active years: 2012-2016.
Company Filing History:
Years Active: 2012-2016
Title: James D. Chappell: Innovator in Reovirus Research
Introduction
James D. Chappell is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of virology, particularly in the development of reovirus vaccines. With a total of 2 patents, his work has the potential to impact vaccine development and immune response generation.
Latest Patents
Chappell's latest patents include innovative methods related to reovirus vaccines. The first patent, titled "Reovirus vaccines and methods of use therefor," provides modified reoviruses that carry α-helical epitopes from various pathogens. This invention outlines methods for using these modified reoviruses to generate immune responses against those epitopes in hosts. The second patent, "System for generation of viable reovirus from cloned cDNA," details methods for generating viable reoviruses using only cloned nucleic acid segments representing the RNA segments of the reovirus genome.
Career Highlights
James D. Chappell is affiliated with Vanderbilt University, where he conducts his research. His work at this esteemed institution has allowed him to explore innovative solutions in the field of virology. His contributions have been recognized within the scientific community, showcasing his dedication to advancing medical research.
Collaborations
Chappell has collaborated with notable colleagues, including Terence Dermody and Takeshi Kobayashi. These partnerships have fostered a collaborative environment that enhances the research and development of new virological methods.
Conclusion
James D. Chappell's innovative work in reovirus research exemplifies the impact of dedicated inventors in the field of medicine. His patents and collaborations contribute to the ongoing advancement of vaccine technology and immune response strategies.